Noveris Health Sciences is trading at CA$0.05, up 11.11%, with no company-specific announcement identified to explain the October 29 move. - Available company-news listings show earlier announcements, not a fresh catalyst. - Broader U.S. markets were lower, but available evidence does not establish a market-wide explanation for the gain. - Current-session trading-volume or activity data was not provided, so activity behind the move is unclear.